Idera Pharmaceuticals Inc (IDRA)

[Citrati]

General market and IBB red ink this morning are weighing on the bio sector.
Keep scanning for sale prices.
IDRA is a perfect example. Great news, stock is down. In fact, below Baker Bro last purchase of $20million worth at $3.75.
Best Green Wishes to All.

The current average broker recommendation for Idera Pharmaceuticals, Inc., according to Zack’s research, is 1.00, based on 2 broker ratings. With 1 being a strong buy and 5 being a strong sell, this means that on a consensus basis, analysts currently see Idera Pharmaceuticals, Inc. as a strong buy. The 12 month target consensus price estimate among these analysts for Idera Pharmaceuticals, Inc. is currently at $7.00.